MedTrace Logo

Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders

NCT06661252 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 111

Last updated 2026-04-13

No results posted yet for this study

Summary

This research study is an observational, single site study quantifying expression of biomarkers of respiratory disease in nasal fluid using the ABEL microsampler device. The primary objective of this study is to compare biomarker expression between healthy controls and participants with respiratory disorders such as chronic obstructive pulmonary disorder (COPD), hayfever, chronic sinusitis, asthma and rhinitis.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma Patients
  • Asthma and Rhinitis
  • Asthmatic Patients
  • Asthma, Chronic Obstructive Pulmonary Disease (COPD)
  • Rhinitis Allergic
  • Rhinitis, Allergic, Perennial and/or Seasonal
  • Non-allergic Rhinitis
  • Chronic Sinusitis With or Without Nasal Polyps
  • Healthy Volunteers

Interventions

DEVICE

ABEL microsampler device

The ABEL microsampler device will be used to collect nasal fluid samples for biomarker analysis.

Sponsors & Collaborators

  • Diag-Nose Medical Pty Ltd

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-08
Primary Completion
2025-11-25
Completion
2025-11-25

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06661252 on ClinicalTrials.gov